shutterstock_1462333919_pavel_kapysh
Pavel Kapysh / Shutterstock.com
3 September 2020AmericasSarah Morgan

CareDx drops transplant testing patent suit

California-based molecular diagnostics company CareDx and Stanford University have dropped their patent infringement suit against Tai Diagnostics, nearly five months after filing the complaint.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
27 March 2019   Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.
Europe
11 February 2020   In a victory for the University of California, the European Patent Office has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.

More on this story

Americas
27 March 2019   Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.
Europe
11 February 2020   In a victory for the University of California, the European Patent Office has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.

More on this story

Americas
27 March 2019   Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected.
Europe
11 February 2020   In a victory for the University of California, the European Patent Office has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.